Icarus Capital Corp. (TSXV:ICRS)
Canada · Delayed Price · Currency is CAD 0.0300
0.00 (0.00%)
Aug 5, 2026, 9:30 AM EST
Icarus Capital Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.62 | 1.45 | 1.27 | 0.39 | - | - | |
Revenue Growth | 16.98% | 13.52% | 224.42% | - | - | - |
Cost of Revenue | 0.98 | 0.9 | 0.85 | 0.27 | - | - |
Gross Profit | 0.64 | 0.55 | 0.42 | 0.12 | - | - |
Selling, General & Admin | 0.68 | 0.61 | 0.6 | 0.24 | 0.1 | 0.01 |
Amortization of Goodwill & Intangibles | - | - | - | 0.02 | - | - |
Other Operating Expenses | - | - | - | 0.01 | - | - |
Operating Expenses | 0.68 | 0.61 | 0.6 | 0.26 | 0.14 | 0.01 |
Operating Income | -0.04 | -0.06 | -0.17 | -0.14 | -0.14 | -0.01 |
Interest Expense | -0.05 | -0.06 | -0.07 | -0.02 | -0 | - |
Other Non Operating Income (Expenses) | -0.01 | - | - | -0.02 | -0.02 | -0 |
EBT Excluding Unusual Items | -0.1 | -0.12 | -0.24 | -0.19 | -0.16 | -0.01 |
Impairment of Goodwill | - | - | -0.31 | - | - | - |
Other Unusual Items | - | - | 0.02 | - | - | - |
Pretax Income | -0.1 | -0.12 | -0.53 | -0.19 | -0.16 | -0.01 |
Income Tax Expense | 0.01 | 0.01 | 0 | 0 | - | - |
Net Income | -0.11 | -0.13 | -0.54 | -0.19 | -0.16 | -0.01 |
Net Income to Common | -0.11 | -0.13 | -0.54 | -0.19 | -0.16 | -0.01 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 9 | 9 | 7 | 7 | 2 | - |
Shares Outstanding (Diluted) | 9 | 9 | 7 | 7 | 2 | - |
Shares Change | 26.68% | 28.14% | 1.92% | 228.39% | - | - |
EPS (Basic) | -0.01 | -0.02 | -0.08 | -0.03 | -0.08 | - |
EPS (Diluted) | -0.01 | -0.02 | -0.08 | -0.03 | -0.08 | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 39.66% | 37.79% | 33.27% | 30.45% | - | - |
Operating Margin | -2.40% | -4.19% | -13.70% | -36.85% | - | - |
Profit Margin | -6.77% | -9.28% | -42.06% | -49.68% | - | - |
EBITDA | 0.03 | 0.01 | -0.05 | -0.13 | - | - |
EBITDA Margin | 2.07% | 0.92% | -4.01% | -32.01% | - | - |
D&A For EBITDA | 0.07 | 0.07 | 0.12 | 0.02 | - | - |
EBIT | -0.04 | -0.06 | -0.17 | -0.14 | -0.14 | -0.01 |
EBIT Margin | -2.39% | -4.19% | -13.70% | -36.85% | - | - |
Revenue as Reported | 1.62 | 1.45 | 1.27 | - | - | - |
Advertising Expenses | - | - | - | 0.01 | - | - |